Finance
Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal
Sun Pharmaceutical Industries Ltd. agreed to acquire New York-listed women’s health-care company Organon & Co., in what is likely to be one of the biggest India outbound deals in years.
B
Bloomberg
April 27, 2026·1 min read
Image: Bloomberg
Sun Pharmaceutical Industries Ltd. agreed to acquire New York-listed women’s health-care company Organon & Co., in what is likely to be one of the biggest India outbound deals in years.
Original article
Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal
Published by Bloomberg